Glycopolymeric Micellar Nanoparticles for Platelet-Mediated Tumor-Targeted Delivery of Docetaxel for Cancer Therapy
Open Access
- 19 August 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (34) , 44528-44537
Abstract
The high level of accumulation of therapeutic agents in tumors is crucial for cancer treatment. Compared to the passive tumor-targeting effect, active tumor-targeting delivery systems, primarily mediated by peptides with high production costs and reduced circulation time, are highly desired. Platelet-driven technologies have opened new avenues for targeted drug delivery prevalently through a membrane coating strategy that involves intricate manufacturing procedures or the fucoidan-mediated hitchhiking method with limited platelet affinity. Here, a novel type of amphiphilic glycopolymer self-assembled micellar nanoparticle has been developed to adhere to naturally activated platelets in the blood. The simultaneous integration of fucose and sialic acid segments into glycopolymers enables closer mimicry of the structure of P-selectin glycoprotein ligand-1 (PSGL-1), thereby increasing the affinity for activated platelets. It results in the formation of glycopolymeric micelle-platelet hybrids, facilitating targeted drug delivery to tumors. The selective platelet-assisted cellular uptake of docetaxel (DTX)-loaded glycopolymeric micelles leads to lower IC50 values against 4T1 cells than that of free DTX. The directed tumor-targeting effect of activated platelets has significantly improved the tumor accumulation capacity of the glycopolymeric nanoparticles, with up to 21.0% found in tumors within the initial 0.2 h. Additionally, with acid-responsive drug release and inherent antimetastasis properties, the glycopolymeric nanoparticles ensured potent therapeutic efficacy, prolonged survival time, and reduced cardiotoxicity, presenting a new and unexplored strategy for platelet-directed drug delivery to tumors, showing promising prospects in treating localized tumors and preventing tumor metastasis.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFC2103100)
- Natural Science Foundation of Jiangsu Province (BK20180625)
- National Natural Science Foundation of China (22008090)
This publication has 46 references indexed in Scilit:
- Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatmentActa Pharmaceutica Sinica B, 2021
- Drug Targeting via Platelet Membrane–Coated NanoparticlesSmall Structures, 2020
- Glycopolymer Code: Programming Synthetic Macromolecules for Biological TargetingMacromolecular Chemistry and Physics, 2020
- Stability, Stimuli‐Responsiveness, and Versatile Sorption Properties of a Dynamic Covalent Acylhydrazone GelGlobal Challenges, 2018
- Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectinBiomaterials, 2018
- Development of Polymer Microcapsules Functionalized with Fucoidan to Target P‐Selectin Overexpressed in Cardiovascular DiseasesAdvanced Healthcare Materials, 2016
- Anticancer Platelet‐Mimicking NanovehiclesAdvanced Materials, 2015
- Peptide‐Tunable Drug Cytotoxicity via One‐Step Assembled Polymer NanoparticlesAdvanced Materials, 2013
- Templated Assembly of pH‐Labile Polymer‐Drug Particles for Intracellular Drug DeliveryAdvanced Functional Materials, 2012
- Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human plateletsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009